Silo Pharma (NASDAQ: SILO) announced that its wholly owned managed AI agent subsidiary, QwikAgents, has expanded its platform with support for customer-supplied NVIDIA API keys and the addition of the Hermes agent runtime. The move makes NVIDIA the fifth supported bring-your-own-key (BYOK) provider for QwikAgents, joining Anthropic, OpenAI, Google, and DeepSeek. Customers can now use their own NVIDIA API keys to access NVIDIA Nemotron models, giving them greater control over model selection and cost management.
In addition to NVIDIA support, QwikAgents has added Hermes as an alternative to the existing OpenClaw runtime. This allows customers to choose either runtime when creating an AI agent, providing flexibility to match specific performance, compatibility, or security requirements. Both runtimes operate on QwikAgents infrastructure, which includes managed hosting, persistent memory, model routing, and dedicated compute. This means that regardless of the runtime selected, users benefit from a fully managed environment that handles the underlying complexities of AI agent deployment.
The expansion is significant for businesses looking to integrate AI agents into their operations without being locked into a single vendor or runtime. By supporting multiple BYOK providers, QwikAgents reduces dependency on any one AI model supplier and allows organizations to leverage existing contracts or preferred providers. The addition of Hermes further differentiates the platform by offering a second runtime option, which could appeal to developers seeking specific technical capabilities or those who require an alternative to OpenClaw for compliance or architectural reasons.
For investors, the announcement highlights Silo Pharma's efforts to diversify beyond its biopharmaceutical roots. Silo Pharma is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, with a therapeutic focus on underserved conditions such as stress-induced psychiatric disorders, chronic pain, and central nervous system diseases. Its portfolio includes SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The QwikAgents subsidiary represents a foray into the AI sector, which could provide additional revenue streams and technological synergies.
The news comes amid growing demand for AI agent solutions that offer customization and control. Enterprises are increasingly wary of vendor lock-in and seek platforms that support multiple model providers. QwikAgents' BYOK approach addresses this by letting customers use their own API keys, which can simplify procurement and billing. The managed infrastructure ensures that even with BYOK, customers receive a seamless experience with persistent memory and model routing handled by the platform.
For more details, the full press release is available at https://ibn.fm/AXpqr. The latest news and updates relating to SILO can be found in the company's newsroom at https://ibn.fm/SILO.
AINewsWire (AINewsWire), a specialized communications platform focused on artificial intelligence, is part of the Dynamic Brand Portfolio at IBN. The network provides wire solutions through InvestorWire, including editorial syndication to 5,000+ outlets and social media distribution, among other services. For more information, visit www.AINewsWire.com. The full terms of use and disclaimers are available at https://www.AINewsWire.com/Disclaimer.
